Literature DB >> 8869270

Experimental models and behavioural tests used in the study of Parkinson's disease.

J Mokrý1.   

Abstract

The present review brings the survey of the most frequently used behavioural tests in experimental models of Parkinson's disease (PD). Although there is no spontaneous occurrence of parkinsonism in animals, several experimental animal models of PD have been developed to achieve the same clinical features in animals. The techniques employing neurotoxins in lesioning the nigrostriatal dopaminergic (DA) system have a large selectivity and reproducibility. The most frequently used neurotoxins are 1-methyl-4-phenyl- 1,2,3,6-tetrahydropyridine (MPTP) and 6-hydroxydopamine (6-OHDA). MPTP-lesioned monkeys mimic best the symptomatology of PD in human patients while rats appear to be refractory to MPTP. For that reason, 6-OHDA is used to damage the substantia nigra in a rodent model. Behavioural tests of animals with nigrostriatal lesion represent valuable non-invasive methods for assessing the influence of damaged DA system on locomotor activity. The most frequently used experimental model of PD is the drug-evoked rotation in 6-OHDA unilaterally lesioned rats. This model produces well-defined and stable behavioural deficits. The rotation test is a useful parameter for evaluating imbalances of dopamine in both striata of the hemi-parkinsonian rat model. T-maze, treadmill running test or sensorimotor tests are used to evaluate spontaneous locomotor activity of lesioned animals. Skilled motor tasks measure the influence of dopamine-depleting lesions on complex motor acts. Transplantation of DA tissue into the striatum offers a new approach to the treatment of PD. Experimental models and behavioural tests are used to evaluate the extent of graft-induced recovery of MPTP- or 6-OHDA-lesioned animals. Different results obtained after the use of different tests reflect the level of graft integration into the host circuitry.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8869270

Source DB:  PubMed          Journal:  Physiol Res        ISSN: 0862-8408            Impact factor:   1.881


  14 in total

1.  Effects of age, gender, and gonadectomy on neurochemistry and behavior in animal models of Parkinson's disease.

Authors:  Andrea Tamás; Andrea Lubics; István Lengvári; Dóra Reglodi
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

2.  Purified mouse dopamine neurons thrive and function after transplantation into brain but require novel glial factors for survival in culture.

Authors:  A E Donaldson; C E Marshall; Ming Yang; S Suon; Lorraine Iacovitti
Journal:  Mol Cell Neurosci       Date:  2005-09       Impact factor: 4.314

3.  Substantia nigra vulnerability after a single moderate diffuse brain injury in the rat.

Authors:  Daniel R van Bregt; Theresa Currier Thomas; Jason M Hinzman; Tuoxin Cao; Mei Liu; Guoying Bing; Greg A Gerhardt; James R Pauly; Jonathan Lifshitz
Journal:  Exp Neurol       Date:  2011-12-09       Impact factor: 5.330

4.  Automated quantification of dopaminergic immunostained neurons in substantia nigra using freely available software.

Authors:  Susana Ruth Valdez; Ricardo Jorge Cabrera; María Paula Bonaccorso Marinelli; Gustavo Baiardi
Journal:  Med Biol Eng Comput       Date:  2022-08-26       Impact factor: 3.079

Review 5.  Effects of Cannabidiol on Locomotor Activity.

Authors:  Fabrizio Calapai; Luigi Cardia; Gioacchino Calapai; Debora Di Mauro; Fabio Trimarchi; Ilaria Ammendolia; Carmen Mannucci
Journal:  Life (Basel)       Date:  2022-04-27

6.  Treadmill gait analysis does not detect motor deficits in animal models of Parkinson's disease or amyotrophic lateral sclerosis.

Authors:  Thomas S Guillot; Seneshaw A Asress; Jason R Richardson; Jonathan D Glass; Gary W Miller
Journal:  J Mot Behav       Date:  2008-11       Impact factor: 1.328

7.  Selective loss of dopaminergic nigro-striatal neurons in brains of Atm-deficient mice.

Authors:  R Eilam; Y Peter; A Elson; G Rotman; Y Shiloh; Y Groner; M Segal
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

Review 8.  Glutamate receptors and Parkinson's disease: opportunities for intervention.

Authors:  Michael J Marino; Ornella Valenti; P Jeffrey Conn
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

9.  Morphological and metabolic changes in the nigro-striatal pathway of synthetic proteasome inhibitor (PSI)-treated rats: a MRI and MRS study.

Authors:  Stefano Delli Pizzi; Cosmo Rossi; Vincenzo Di Matteo; Ennio Esposito; Simone Guarnieri; Maria Addolorata Mariggiò; Raffaella Franciotti; Massimo Caulo; Astrid Thomas; Marco Onofrj; Armando Tartaro; Laura Bonanni
Journal:  PLoS One       Date:  2013-02-19       Impact factor: 3.240

10.  The neurotoxicity of DOPAL: behavioral and stereological evidence for its role in Parkinson disease pathogenesis.

Authors:  W Michael Panneton; V B Kumar; Qi Gan; William J Burke; James E Galvin
Journal:  PLoS One       Date:  2010-12-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.